The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction A Kolodny, DT Courtwright, CS Hwang, P Kreiner, JL Eadie, TW Clark, ... Annual review of public health 36 (1), 559-574, 2015 | 1772 | 2015 |
Trends in the concomitant prescribing of opioids and benzodiazepines, 2002− 2014 CS Hwang, EM Kang, CJ Kornegay, JA Staffa, CM Jones, JK McAninch American journal of preventive medicine 51 (2), 151-160, 2016 | 214 | 2016 |
Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access L Rutkow, L Turner, E Lucas, C Hwang, GC Alexander Health affairs 34 (3), 484-492, 2015 | 154 | 2015 |
Impact of abuse‐deterrent OxyContin on prescription opioid utilization CS Hwang, HY Chang, GC Alexander Pharmacoepidemiology and drug safety 24 (2), 197-204, 2015 | 67 | 2015 |
Prescription drug abuse: a national survey of primary care physicians CS Hwang, LW Turner, SP Kruszewski, A Kolodny, GC Alexander JAMA internal medicine 175 (2), 302-304, 2015 | 54 | 2015 |
Primary care physicians’ knowledge and attitudes regarding prescription opioid abuse and diversion CS Hwang, LW Turner, SP Kruszewski, A Kolodny, GC Alexander The clinical journal of pain 32 (4), 279-284, 2016 | 52 | 2016 |
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions CL Bennett, MW Schoen, S Hoque, BJ Witherspoon, DM Aboulafia, ... The Lancet Oncology 21 (12), e575-e588, 2020 | 28 | 2020 |
Patterns of immediate-release and extended-release opioid analgesic use in the management of chronic pain, 2003-2014 CS Hwang, EM Kang, Y Ding, J Ocran-Appiah, JK McAninch, JA Staffa, ... JAMA Network Open 1 (2), e180216-e180216, 2018 | 22 | 2018 |
Important statistical considerations in the evaluation of post‐market studies to assess whether opioids with abuse‐deterrent properties result in reduced abuse in the community K By, JK McAninch, SL Keeton, A Secora, CJ Kornegay, CS Hwang, T Ly, ... Pharmacoepidemiology and Drug Safety 27 (5), 473-478, 2018 | 11 | 2018 |
A Clinical Triad with Fatal Implications: Recrudescent Diffuse Large B-cell Non-Hodgkin Lymphoma Presenting in the Leukemic Phase with an Elevated Serum Lactic Acid Level and … CS Hwang, DG Hwang, DM Aboulafia Clinical Medicine Insights: Blood Disorders 14, 2634853521994094, 2021 | 6 | 2021 |
Changes in Induced Medical and Procedural Abortion Rates in a Commercially Insured Population, 2018 to 2022: An Interrupted Time-Series Analysis CS Hwang, AS Kesselheim, A Sarpatwari, KF Huybrechts, G Brill, ... Annals of Internal Medicine 176 (11), 1508-1515, 2023 | 4 | 2023 |
Removing the FDA’s boxed hepatotoxicity warning and liver function testing requirement for ambrisentan WB Feldman, M Mahesri, A Sarpatwari, KF Huybrechts, Y Zhu, CS Hwang, ... JAMA Network Open 7 (7), e2419873-e2419873, 2024 | 2 | 2024 |
Unique challenges and the changing face of oncology during the COVID-19 pandemic and beyond CS Hwang, CL Bennett, DM Aboulafia Journal of Cancer Research Therapy 8 (5), 28-29, 2020 | 2 | 2020 |
Strategies to Help Patients Navigate High Prescription Drug Costs HS Lalani, CS Hwang, AS Kesselheim, BN Rome JAMA 332 (20), 1741-1749, 2024 | 1 | 2024 |
An unusual presentation of Pseudomonas citronellolis bacteraemia and Campylobacter gastroenteritis infection in a human – a case report and literature review CS Hwang, E Rahmati, AJ Gerbino, TM Rose, P Verma, MA Schwartz Access Microbiology 5 (6), 000479. v3, 2023 | 1 | 2023 |
Bridging to value with codes that promote care management CS Hwang The American Journal of Managed Care 26 (11), 2020 | 1 | 2020 |
Primary care–oriented pathways to support population-based payment models LM Marcotte, A Chen, CS Hwang, JM Liao J Clin Pathways 5 (7), 39-42, 2019 | 1 | 2019 |
Primary Medication Adherence in Medicare Beneficiaries Prescribed Sacubitril-Valsartan or Renin-Angiotensin System Blockers for Heart Failure with Reduced Ejection Fraction CS Hwang, RJ Desai, AS Kesselheim, R Levin, BN Rome American Heart Journal, 2024 | | 2024 |
Tramadol use in US Adults With Commercial Health Insurance, 2005–2021 CA Basham, H Edrees, KF Huybrechts, CS Hwang, BT Bateman, K Bykov American Journal of Preventive Medicine 67 (4), 558-567, 2024 | | 2024 |
State Spending Targets for Prescription Drugs CS Hwang, HS Lalani, BN Rome JAMA Health Forum 5 (7), e241663-e241663, 2024 | | 2024 |